Tales of power in biotechnology regulation: the EU ban on BST

Abstract

Biotechnology regulation has been dogged by allegations of bias, usually phrased in terms of ‘conflicts of interest’. Social constructionist analyses of regulatory science have shown up serious epistemological difficulties with such ‘interest’ explanations of regulatory power, but in the process they have also destabilised the platforms such as ‘objectivity’, upon which critiques of regulatory bias are usually grounded. This paper argues that their critical impotence follows from not being constructivist enough. Building on Hajer’s notions of ‘story-lines’ and ‘discourse coalitions’, it argues that recovering the non-human, material components that construct regulation offers sufficiently firm ground for evaluating regulatory power even in the absence of the firm benchmarks assumed by interest accounts. The paper develops this approach by focusing on a single story-line, characterised as ‘scientism’, as it is deployed in the build up to a European Union (EU) ban on bovine somatotrophin, the first food-related product of the ‘new biotechnology’. The essay ends by discussing how far this retrospective analysis can help us to understand and intervene in the current and future EU regulation of biotechnology.